161 related articles for article (PubMed ID: 35419526)
1. Suitability for Kidney Transplantation in AL Amyloidosis: A Survey Study of Transplant and Amyloidosis Physicians.
Lam R; Lim MA; Dember LM
Kidney360; 2021 Dec; 2(12):1987-1997. PubMed ID: 35419526
[TBL] [Abstract][Full Text] [Related]
2. High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease.
Batalini F; Econimo L; Quillen K; Sloan JM; Sarosiek S; Brauneis D; Havasi A; Stern L; Dember LM; Sanchorawala V
Biol Blood Marrow Transplant; 2018 Jan; 24(1):127-132. PubMed ID: 28865972
[TBL] [Abstract][Full Text] [Related]
3. Autologous stem cell transplantation following simultaneous liver and kidney transplantation in severe amyloid light chain amyloidosis associated with multiple myeloma: a case report.
Al-Zoairy R; Viveiros A; Zoller H; Schneeberger S; Oberhuber G; Gunsilius E; Tilg H; Wolf D; Rudzki JD
J Med Case Rep; 2020 Oct; 14(1):201. PubMed ID: 33099313
[TBL] [Abstract][Full Text] [Related]
4. Renal transplant outcomes in amyloidosis.
Law S; Cohen O; Lachmann HJ; Rezk T; Gilbertson JA; Rowczenio D; Wechalekar AD; Hawkins PN; Motallebzadeh R; Gillmore JD
Nephrol Dial Transplant; 2021 Jan; 36(2):355-365. PubMed ID: 33439995
[TBL] [Abstract][Full Text] [Related]
5. A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis.
Heybeli C; Bentall A; Wen J; Alexander MP; Buadi FK; Cosio FG; Dean PG; Dispenzieri A; Dingli D; El Ters M; Gertz MA; Hatem A; Kapoor P; Khamash H; Kourelis T; Kumar S; Lorenz EC; Mai M; Muchtar E; Murray DL; Prieto M; Schinstock CA; Stegall MD; Warsame R; Leung N
Kidney Int; 2021 Mar; 99(3):707-715. PubMed ID: 32712168
[TBL] [Abstract][Full Text] [Related]
6. Nephrologists' perceptions of renal transplant as treatment of choice for end-stage renal disease, preemptive transplant, and transplanting older patients: an international survey.
Ghahramani N; Karparvar ZY; Ghahramani M; Shrivastava P
Exp Clin Transplant; 2011 Aug; 9(4):223-9. PubMed ID: 21819365
[TBL] [Abstract][Full Text] [Related]
7. Improved outcomes for kidney transplantation in AL amyloidosis: impact on practice.
Nuvolone M; Merlini G
Kidney Int; 2019 Feb; 95(2):258-260. PubMed ID: 30665564
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation.
Herrmann SM; Gertz MA; Stegall MD; Dispenzieri A; Cosio FC; Kumar S; Lacy MQ; Dean PG; Prieto M; Zeldenrust SR; Buadi FK; Russell SJ; Nyberg SL; Hayman SR; Dingli D; Fervenza FC; Leung N
Nephrol Dial Transplant; 2011 Jun; 26(6):2032-6. PubMed ID: 21543655
[TBL] [Abstract][Full Text] [Related]
9. Clinical Outcomes and Effectiveness of Heart Transplantation in Patients With Systemic Light-chain Cardiac Amyloidosis.
Jeong H; Hwang I; Kim JH; Cho H; Kim MS; Lee SE; Choi HI; Jung SH; Lee JW; Yun TJ; Park JJ; Kim M; Go H; Park CS; Yoon DH; Kim JJ
Transplantation; 2022 Nov; 106(11):2256-2262. PubMed ID: 35706094
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of kidney transplantation in AL amyloidosis.
Angel-Korman A; Stern L; Sarosiek S; Sloan JM; Doros G; Sanchorawala V; Havasi A
Kidney Int; 2019 Feb; 95(2):405-411. PubMed ID: 30580886
[TBL] [Abstract][Full Text] [Related]
11. Nephrologists' management of patient medications in kidney transplantation: results of an online survey.
Crawford K; Low JK; Manias E; Walker R; Toussaint ND; Mulley W; Dooley M; Ierino FL; Hughes P; Goodman DJ; Williams A
J Eval Clin Pract; 2015 Oct; 21(5):879-85. PubMed ID: 26371625
[TBL] [Abstract][Full Text] [Related]
12. Bilateral kidney infarction due to primary Al amyloidosis: a first case report.
Mihout F; Joseph L; Brocheriou I; Leblond V; Varnous S; Ronco P; Plaisier E
Medicine (Baltimore); 2015 May; 94(17):e777. PubMed ID: 25929920
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines.
Sanchorawala V; Boccadoro M; Gertz M; Hegenbart U; Kastritis E; Landau H; Mollee P; Wechalekar A; Palladini G
Amyloid; 2022 Mar; 29(1):1-7. PubMed ID: 34783272
[TBL] [Abstract][Full Text] [Related]
14. Perceptions of patient candidacy for kidney transplant in the United States: a qualitative study comparing rural and urban nephrologists.
Ghahramani N; Sanati-Mehrizy A; Wang C
Exp Clin Transplant; 2014 Feb; 12(1):9-14. PubMed ID: 24471717
[TBL] [Abstract][Full Text] [Related]
15. Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation.
Sidiqi MH; Aljama MA; Muchtar E; Buadi FK; Warsame R; Lacy MQ; Dispenzieri A; Dingli D; Leung N; Gonsalves WI; Kumar SK; Kapoor P; Kourelis TV; Hogan WJ; Gertz MA
Blood Adv; 2018 Apr; 2(7):769-776. PubMed ID: 29615413
[TBL] [Abstract][Full Text] [Related]
16. [Inadequate involvement of nephrologist/dialysis physicians in transplantation: based on the findings of a survey of transplant recipients].
Shibagaki Y; Toma H; Teraoka S
Nihon Jinzo Gakkai Shi; 2004 Jan; 46(1):20-5. PubMed ID: 15007907
[TBL] [Abstract][Full Text] [Related]
17. The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantation.
Leung N; Kumar SK; Glavey SV; Dispenzieri A; Lacy MQ; Buadi FK; Hayman SR; Dingli D; Kapoor P; Zeldenrust SR; Russell SJ; Lust JA; Hogan WJ; Rajkumar SV; Gastineau DA; Kourelis TV; Lin Y; Gonsalves WI; Go RS; Gertz MA
Nephrol Dial Transplant; 2016 Aug; 31(8):1284-9. PubMed ID: 26627634
[TBL] [Abstract][Full Text] [Related]
18. The Role of Autologous Stem Cell Transplantation in Amyloidosis.
Vaxman I; Dispenzieri A
Oncology (Williston Park); 2021 Aug; 35(8):471-478. PubMed ID: 34398591
[TBL] [Abstract][Full Text] [Related]
19. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
20. Current and emerging views and treatments of systemic immunoglobulin light-chain (Al) amyloidosis.
Comenzo RL
Contrib Nephrol; 2007; 153():195-210. PubMed ID: 17075231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
